Info from Supporting Partners

Register for the webinar here: https://us06web.zoom.us/meeting/register/fAHaXREDSP2h3RqKMbnq4Q Scientific Webinar by Neobiomics We are excited to invite you to our exclusive autumn webinar session, where leading neonatologists will discuss their clinical experiences with probiotics. DATE: 18 November 2025 TIME: 16.30-17.30 CET What to expect: · Prof. Dr. Christoph Härtel, Head of the Pediatric Department at University Hospital Würzburg, will share his team’s experience with probiotics in neonatal care — from early implementation to clinical outcomes. He will highlight key learnings, clinical results, and practical insights from their NICU experience. · Dr. A…

Neobiomics is pleased to invite you to the upcoming NeoMega36® Webinar, where leading experts in neonatology will share the latest scientific evidence and clinical experiences on ARA and DHA supplementation in extremely preterm infants. Date: 12 November 2025 Time: 15.30 – 16.30 CET Register Here: https://us06web.zoom.us/meeting/register/JxHc93kdQ9yTDmyUc8QUbA Topic: ARA & DHA Supplementation in Extremely Preterm Infants- Clinical Experiences of NeoMega36® from 2 Europen NICUs What to expect: Dr. Norbert Teig will provide an overview of nearly two years of clinical experience using ARA and DHA supplementation in extremely preterm infants in his German NICU. He will…

Webinar: Belfast Trust NICU Experience with Probiotics: One Year of Clinical and Cost Insights Scientific Webinar by Neobiomics We are excited to invite you to our exclusive autumn webinar session, where leading neonatologists will discuss their clinical experiences with probiotics. DATE: 2 October TIME: 16.00-16.40 CET WHAT TO EXPECT: Dr. Adam Reynolds and his team recently presented a poster on their NICU’s experience with probiotics at the BAPM British Association of Perinatal Medicine Conference in September 2025. In this webinar, Dr. Reynolds will share insights from the first year of implementation, highlighting both the clinical outcomes and the cost aspects of int…

Erfahrungen mit NeoMega36® in Deutschland Veranstaltet von Neobiomics, Karolinska Institutet Science Park! Wir freuen uns, Sie zu unserem exklusiven Webinar einzuladen, bei dem führende Neonatolog:innen ihre klinischen Erfahrungen mit NeoMega36® teilen. NeoMega36® ist eine innovative Lösung mit Arachidonsäure (ARA) und Docosahexaensäure (DHA), die die normale Sehentwicklung bei extrem frühgeborenen Säuglingen unterstützt. ⬇️ Jetzt registrieren ⬇️ https://bit.ly/NeoMega36_webinar_18Sept WEBINAR-INFORMATIONEN Datum & Uhrzeit: 18. September, 15:30 MEZ Dauer: 40 Minuten AGENDA: Einführung zu NeoMega36® Dr. Stefan Johansson, MD, PhD, Neonatologe und Assoziierter Professor …

12 June 2025, 4:00 PM 5:00 PM Safety and Use of Probiotics in Neonatal Care – Insights from Imperial College & Lancashire Teaching Hospitals in UK By Neobiomics, Karolinska Institutet Science Park We are excited to invite you to our exclusive webinar session in June, where leading neonatologists will discuss their clinical experiences with Proprems®, a High-Quality, Rigorous Manufacturing Control, Multi-strain probiotics B. infantis Bb-02, B. lactis BB-12®, S. thermophilus TH-4®. ➡️CLICK HERE TO REGISTER ⬅️ WEBINAR INFORMATION: DATE and TIME: 12 June, 16.00 CET DURATION: 50 minutes IN THIS WEBINAR, THE SPEAKERS WILL COVER: • Short introduction about ProPrems® by Dr. …

Erfahrungen im Einsatz von ProPrems® und NeoMega36® in Deutschland Von Neobiomics, Karolinska Institutet Science Park! Wir freuen uns, Sie zu unserem exklusiven Webinar einzuladen, bei dem führende Neonatolog:innen ihre klinischen Erfahrungen mit ProPrems® und NeoMega36® teilen. ProPrems® ist ein hochwertiges, streng kontrolliertes Multistamm-Probiotikum mit B. infantis Bb-02, B. lactis BB-12® und S. thermophilus TH-4®. NeoMega36® ist eine innovative Lösung mit Arachidonsäure (ARA) und Docosahexaensäure (DHA), die die normale Sehentwicklung bei extrem frühgeborenen Säuglingen unterstützt. ⬇️ Jetzt registrieren ⬇️ https://us06web.zoom.us/meeting/register/2reebU5jSYKYvBNQsb…

Welcome to the NeoMega36 Webinar® ARA and DHA Supplementation: Pioneers & First Experiences in European NICUs – Insights from German and Greek Hospitals By Neobiomics, Karolinska Institutet Science Park! We are excited to invite you to our exclusive webinar, where leading neonatologists will discuss their clinical experiences with NeoMega36®. An innovative solution with arachidonic acid (ARA) and docosahexaenoic acid (DHA), supporting the Normal Vision Development in Extremely Preterm infants. CLICK HERE TO REGISTER WEBINAR INFORMATION DATE and TIME: 20 May, 15.00 CET DURATION: 50 minutes IN THIS WEBINAR, THE SPEAKERS WILL COVER: • Short introduction about NeoMega36® …

1 April - Webinar - ARA and DHA Supplementation: Pioneers & First Experiences in European NICUs – Insights from German and Greek Hospitals - By Neobiomics, Karolinska Institutet Science Park Scientific Webinar by Neobiomics - Karolinska Institutet Science Park We are excited to invite you to our exclusive webinar session in April, where leading doctors will discuss their clinical experiences with Neomega36®. An innovative solution with arachidonic acid (ARA) and docosahexaenoic acid (DHA), supporting the Normal Vision Development in Extremely Preterm infants. DATE: 1 April TIME: 15.00-16:00 CET What to expect: · First-hand experiences from doctors using Neom…

20 March - Webinar – Safety and Use of Probiotics in Neonatal Care – Insights from Imperial College & Lancashire Teaching Hospitals in UK - By Neobiomics, Karolinska Institutet Science Park Scientific Webinar by Neobiomics - Karolinska Institutet Science Park We are excited to invite you to our exclusive webinar session in March, where leading doctors will discuss their clinical experiences with Proprems®. High-Quality, Rigorous Manufacturing Control, Multi-strain probiotics B. infantis Bb-02, B. lactis BB-12®, S. thermophilus TH-4®. DATE: 20 March TIME: 14.00-15:00 CET What to expect: · First-hand experiences from doctors using Proprems · Discussion o…

After years of dedicated collaboration among leading Dutch hospitals, the ABC3 study has been published in The Lancet Regional Health. We are excited to invite you to our next Concord Talk on January 14, with lead investigator Prof. Arjan te Pas. In this session, Prof. Te Pas will: Present the results of the ABC3 trial Share key insights and lessons learned from over a decade of the ABC project Explore the implications of the findings and the next steps in advancing Physiological-Based Cord Clamping (PBCC). Prof. Te Pas is a neonatologist and professor of perinatal trans…